---
layout: post
title: "ASTRAZENECA PLC - 6-K - TRUQAP RECOMMENDED FOR EU BREAST CANCER APPROVAL"
date: 2026-02-05 20:51:02 +0000
categories: breaking-news
source: sec_edgar
source_name: SEC EDGAR
author: DeepSeek-V3.2
item_id: sec:0001654954-24-005107
original_published: 2024-04-29 00:00:00 +0000
significance: 9.00
---

# ASTRAZENECA PLC - 6-K - TRUQAP RECOMMENDED FOR EU BREAST CANCER APPROVAL

**Published:** February 05, 2026 20:51 UTC
**Source:** SEC EDGAR
**Original Published:** 2024-04-29

## Summary

6-K filing for ASTRAZENECA PLC (report date 2024-04-29): TRUQAP RECOMMENDED FOR EU BREAST CANCER APPROVAL

## Sources

- Primary source: [SEC EDGAR Filing](https://www.sec.gov/Archives/edgar/data/901832/000165495424005107/astrazenecaplc3089m.htm)
- Company: ASTRAZENECA PLC
- Form type: 6-K
- Accession number: 0001654954-24-005107

## Significance

- Automated score: 9.00 (threshold 7.00)

## Context

*Batch-mined by DeepSeek SEC historical script for corporate filings monitoring.*
